DVC Partners takes majority stake in Spain's Kimitec to fuel global push
What's the deal? DVC PartnersDealroom has a profile for this one. Try Dealroom → has acquired a majority stake in KimitecDealroom has a profile for this one. Try Dealroom →, a Spanish company that develops biological solutions for agriculture. Terms of the deal, announced on July 8, 2026, were not disclosed.
What does Kimitec do? It develops and manufactures natural alternatives for crop nutrition and protection, with applications spanning plant, animal, and human health. The company runs a fully integrated platform combining in-house research and development, production, and a global distribution network.
Why the interest? Kimitec's technology draws on a proprietary artificial intelligence model and one of Europe's largest biotech hubs focused on biostimulants and biocontrol solutions. That setup lets it speed the development of sustainable alternatives to conventional farm inputs.
What's the endgame? With DVC Partners' backing, Kimitec enters a new growth phase aimed at accelerating innovation and strengthening its international presence. The deal reflects DVC Partners' focus on companies with differentiated technology and cross-border potential.
The signal: The investment underscores rising investor appetite for biological alternatives to synthetic agricultural inputs, a market shaped by pressure to make farming more sustainable.
Read more: Capital Riesgo
Image credit: Junta de Andalucía
